Zydus Lifesciences Ltd reported a 36% year-on-year decline in consolidated net profit to ₹939.8 crore for the first quarter of FY27, even as revenue from operations grew 22% to ₹8,017 crore, as profitability came under pressure during the quarter.

AstraZeneca Pharma India reports Q1 profit drop to ₹37.93 crore despite revenue growth to ₹682.79 crore amid higher expenses.

Jubilant Pharmova shares fell after Q1 profit plunged 45% YoY to Rs 56 crore, despite revenue rising 17% to Rs 2,229 crore. The profit decline was attributed to weaker operating…